155 related articles for article (PubMed ID: 37124533)
1. Efficacy and safety of combined immunotherapy and stereotactic radiosurgery in NSCLCBM patients and a novel prognostic nomogram: A real-world study.
Bashir S; Wen L; Zhang P; Ye M; Li Y; Hong W; Zhen J; Lai M; Wang H; Yang Y; Chen X; Luo R; Jia G; Guo Y; Cai L; Xu M
Front Oncol; 2023; 13():1068592. PubMed ID: 37124533
[TBL] [Abstract][Full Text] [Related]
2. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of stereotactic radiosurgery for brain metastases: a single-center retrospective study.
Hao Y; Tang T; Ren J; Li G
Radiol Med; 2023 Oct; 128(10):1271-1283. PubMed ID: 37648956
[TBL] [Abstract][Full Text] [Related]
4. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
6. Safety and efficacy of upfront stereotactic radiosurgery for brain metastases with high cumulative intracranial tumor volume (> 7 ml): analysis of 233 consecutive patients.
Yomo S; Oda K; Oguchi K
Acta Neurochir (Wien); 2021 Apr; 163(4):991-1001. PubMed ID: 33398539
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
8. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
[TBL] [Abstract][Full Text] [Related]
9. Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
Lauko A; Kotecha R; Barnett A; Li H; Tatineni V; Ali A; Patil P; Mohammadi AM; Chao ST; Murphy ES; Angelov L; Suh JH; Barnett GH; Pennell NA; Ahluwalia MS
Sci Rep; 2021 Sep; 11(1):18174. PubMed ID: 34518623
[TBL] [Abstract][Full Text] [Related]
10. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
11. Individualized Nomogram for Predicting Survival in Patients with Brain Metastases After Stereotactic Radiosurgery Utilizing Driver Gene Mutations and Volumetric Surrogates.
Zhou C; Shan C; Lai M; Zhou Z; Zhen J; Deng G; Li H; Li J; Ren C; Wang J; Lu M; Zhang L; Wu T; Zhu D; Kong FS; Chen L; Cai L; Wen L
Front Oncol; 2021; 11():659538. PubMed ID: 34055626
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of stereotactic radiosurgery for recursive partitioning analysis class II/III lung cancer patients with brain metastases in the modern treatment era.
Ha IB; Song JH; Jeong BK; Jeong H; Lee YH; Choi HS; Kang KM
Medicine (Baltimore); 2019 Oct; 98(40):e17390. PubMed ID: 31577744
[TBL] [Abstract][Full Text] [Related]
13. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
[TBL] [Abstract][Full Text] [Related]
14. BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases.
Xu Z; Lee CC; Ramesh A; Mueller AC; Schlesinger D; Cohen-Inbar O; Shih HH; Sheehan JP
J Neurosurg; 2017 Mar; 126(3):726-734. PubMed ID: 27203149
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
Upadhyay R; Klamer BG; Perlow HK; White JR; Bazan JG; Jhawar SR; Blakaj DM; Grecula JC; Arnett A; Mestres-Villanueva MA; Healy EH; Thomas EM; Chakravarti A; Raval RR; Lustberg M; Williams NO; Palmer JD; Beyer SJ
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201564
[TBL] [Abstract][Full Text] [Related]
16. Treatment of brain metastases from gastrointestinal primaries: Comparing whole-brain radiotherapy and stereotactic radiosurgery in terms of survival.
Dincer S; Gurbuz D
North Clin Istanb; 2022; 9(1):47-56. PubMed ID: 35340309
[TBL] [Abstract][Full Text] [Related]
17. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
[TBL] [Abstract][Full Text] [Related]
18. Cumulative Intracranial Tumor Volume as a Prognostic Factor in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery.
Hirshman BR; Compton J; Carroll KT; Ali MA; Wang SG; Chen CC
Acta Neurochir Suppl; 2021; 128():57-69. PubMed ID: 34191062
[TBL] [Abstract][Full Text] [Related]
19. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age.
Watanabe S; Yamamoto M; Sato Y; Kawabe T; Higuchi Y; Kasuya H; Yamamoto T; Matsumura A; Barfod BE
J Neurosurg; 2014 Nov; 121(5):1148-57. PubMed ID: 25061863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
